Home
Our Company
Our Science
Our Indications
- Keratoconus Surgery PRK, LASIK and Cataracts Dry Eye and Glaucoma
- Pipeline
Contact
- Contact
- News

Select Page

TALLC issues new Corporate Presentation

Jan 19, 2021

TALLC issues new Corporate Presentation

January 19, 2021

Pages from Pitch Deck Dec 2020

View the presentation

Recent Posts

TALLC issues new Corporate Presentation
Dr. Damon Smith at Biotech Show Case
TALLC at the Ophthalmology Innovation Summit
TALLC Corporation Announces Grant of New SmartCelle Patent for Enhanced Ocular Delivery of TA-A001
Tetra Bio-Pharma and Altus Formulation Form New Company “TALLC” to Exploit TA-A001

TALLC Inc.Follow

TALLC to Present at ChinaBio

See our updated presentation describing TA-A001 for neovascular disease, wound healing and new ocular bio-distribution data
https://informaconnect.com/chinabio-partnering/

Twitter 1387494048680747008

Archives

January 2021
December 2020
November 2020
July 2020
May 2020

Categories

Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org